Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial
2008
Vitamin D Insufficiency: Disease or No Disease?
2008
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Evolutionary history of Tibetans inferred from whole-genome sequencing
2017 StandoutNobel
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016--Executive Summary
2016
Modified intention to treat reporting in randomised controlled trials: systematic review
2010
Osteoporosis
2019 Standout
Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
2012
Osteoporosis
2006
Rheumatoid arthritis
2018 Standout
A 16-Week Randomized Clinical Trial of 2000 International Units Daily Vitamin D3Supplementation in Black Youth: 25-Hydroxyvitamin D, Adiposity, and Arterial Stiffness
2010
Control of Hair Growth with Parathyroid Hormone (7–34)
1997
Hypovitaminosis D in African Americans Residing in Memphis, Tennessee With and Without Heart Failure
2008
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Insulin-Like Growth Factors I and II. Peptide, Messenger Ribonucleic Acid and Gene Structures, Serum, and Tissue Concentrations*
1989 Standout
Vitamin D and Sunlight
2008
Randomized Trial of Alendronate Plus Vitamin D3 Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency
2011
Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation
2006 StandoutNobel
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
2008 Standout
Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline
2011 Standout
Early-Pregnancy Vitamin D Deficiency and Risk of Preterm Birth Subtypes
2015
Risk factors for low serum 25-hydroxyvitamin D concentrations in otherwise healthy children and adolescents
2007
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65–71 years: a 3-year randomized population-based trial (OSTPRE-FPS)
2010
PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile
2003
Vitamin D Deficiency
2007 Standout
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
2008
Cysteine cathepsins and extracellular matrix degradation
2014
Secondary Causes of Osteoporosis
2012
Maternal and child undernutrition and overweight in low-income and middle-income countries
2013 Standout
Pharmacology of bisphosphonates
2011
Osteocrin, a Novel Bone-specific Secreted Protein That Modulates the Osteoblast Phenotype
2003
Osteoporosis: now and the future
2011 Standout
Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: A multicenter, randomized, open-label, crossover study
2002
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Skeletal remodeling in health and disease
2007 Standout
Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007
2010
Identification and Functional Expression of a Receptor Selectively Recognizing Parathyroid Hormone, the PTH2 Receptor
1995
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Determination of tissue and plasma concentrations of PTHrP in fish: development and validation of a radioimmunoassay using a teleost 1–34 N-terminal peptide
2003
PTHrP(1–36) as a skeletal anabolic agent for the treatment of osteoporosis
1996
Alteration of the hormonal bioactivity of parathyroid hormone-related protein (PTHrP) as a result of limited proteolysis by prostate-specific antigen
1996
Local and Systemic Factors in the Pathogenesis of Osteoporosis
1988
Calcium and vitamin D: Skeletal and extraskeletal health
2008
Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab
2013
Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
2017
Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado
2007
Remodelling the extracellular matrix in development and disease
2014 Standout
Parathyroid hormone-related protein increases DNA synthesis in proximal tubule cells by cyclic AMP- and protein kinase C-dependent pathways
1998
The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation
2006
The role of vitamin D for bone health and fracture prevention
2006
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Evidence-based interventions for improvement of maternal and child nutrition: what can be done and at what cost?
2013 Standout
Sunlight, UV-Radiation, Vitamin D and Skin Cancer: How Much Sunlight Do We Need?
2009
Vitamin D: a D-Lightful health perspective
2008
Metastasis to bone: causes, consequences and therapeutic opportunities
2002 Standout
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Correlation among 25-Hydroxy-Vitamin D Assays
2008
Prevalence of vitamin D inadequacy in a minimal trauma fracture population
2005
The Multifunctional Fish Gill: Dominant Site of Gas Exchange, Osmoregulation, Acid-Base Regulation, and Excretion of Nitrogenous Waste
2004 Standout
Management of severe osteoporosis
2015
Vitamin D levels and early mortality among incident hemodialysis patients
2007
Vitamin D deficiency reduces the benefits of progesterone treatment after brain injury in aged rats
2009
Fortification of orange juice with vitamin D2 or vitamin D3 is as effective as an oral supplement in maintaining vitamin D status in adults
2010
Mechanisms of Bone Metastasis
2004 Standout
Emerging therapeutic concepts for muscle and bone preservation/building
2015
Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations
2008 Standout
Modulation of the immune system by UV radiation: more than just the effects of vitamin D?
2011
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Vitamin D deficiency: a worldwide problem with health consequences
2008 Standout
Etidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women
2008
U.S. Medical Eligibility Criteria for Contraceptive Use, 2010
2011
American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016
2016
PTH/PTHrP Receptor in Early Development and Indian Hedgehog—Regulated Bone Growth
1996 StandoutScience
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer
2008
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Interventions for enhancing medication adherence
2008 Standout
Bone mineralization defects and vitamin D deficiency: Histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients
2009
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
2005 Standout
Systematic Review: Comparative Effectiveness of Treatments to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis
2008
Vitamin D2 Is as Effective as Vitamin D3 in Maintaining Circulating Concentrations of 25-Hydroxyvitamin D
2007
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Interventions for enhancing medication adherence
2014 Standout
Combined batch and continuous flow procedure to the chemo-enzymatic synthesis of biaryl moiety of Odanacatib
2014
Induction of the Vitamin D Receptor Attenuates Autophagy Dysfunction-Mediated Cell Death Following Traumatic Brain Injury.
2017 Standout
Controls of Hair Follicle Cycling
2001 Standout
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
2016
Preterm labor: One syndrome, many causes
2014 StandoutScience
Vitamin D supplementation for women during pregnancy
2016
Photoredox Catalysis in Organic Chemistry
2016 Standout
Prostate Specific Antigen Cleaves Parathyroid Hormone-Related Protein in the PTH-like Domain: Inactivation of PTHrP-Stimulated cAMP Accumulation in Mouse Osteoblasts
1996
Signaling by N- and C-terminal sequences of parathyroid hormone-related protein in hippocampal neurons.
1995
Organocatalysis emerging as a technology
2021 StandoutNobel
Development of a Direct Photocatalytic C–H Fluorination for the Preparative Synthesis of Odanacatib
2015
Neuroendocrine Mechanisms in Pregnancy and Parturition
2010
Odanacatib, a cathepsin-K inhibitor for osteoporosis: A two-year study in postmenopausal women with low bone density
2009
Mice Lacking Cathepsin K Maintain Bone Remodeling but Develop Bone Fragility Despite High Bone Mass
2006
UV Radiation and the Skin
2013 Standout
Visible Light Photocatalysis: Applications and New Disconnections in the Synthesis of Pharmaceutical Agents
2016
Interventions for preventing falls in older people living in the community
2012 Standout
Rapid correction of low vitamin D status in nursing home residents
2008
Association between Vitamin D Deficiency and Primary Cesarean Section
2008
Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation*
1997
FEA to Measure Bone Strength: A Review
2016
Works of Anne E. de Papp being referenced
Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial
2013
Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study
2005
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion
2008
Parathyroid hormone-related protein a peptide of diverse physiologic functions
1993
A cross-sectional study of bone turnover markers in healthy premenopausal women
2007
Response to therapy with once-weekly alendronate 70 mg compared to once-weekly risedronate 35 mg in the treatment of postmenopausal osteoporosis
2004
Parathyroid Hormone-Related Protein as a Prohormone: Posttranslational Processing and Receptor Interactions*
1994
Short-term in vivo precision of BMD and parameters of trabecular architecture at the distal forearm and tibia
2011
Comparison of Weekly Treatment of Postmenopausal Osteoporosis with AlendronateVersusRisedronate Over Two Years
2006
Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study
2002
Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis*
2004
Prevalence of Vitamin D Inadequacy among Postmenopausal North American Women Receiving Osteoporosis Therapy
2005
A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover
2010
Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength
2014
Prevalence of Vitamin D Inadequacy Among Postmenopausal North American Women Receiving Osteoporosis Therapy
2005